Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:AMS NASDAQ:BOLT NASDAQ:CME On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMSAmerican Shared Hospital Services$1.47+2.4%$1.47$1.25▼$3.11$9.70M0.3128,483 shs12,752 shsBOLTBolt Biotherapeutics$4.47+1.1%$4.47$3.75▼$7.20$8.58M1.1626,337 shs19,926 shsCMECME Group$246.03+0.4%$258.54$218.31▼$329.16$89.16B0.252.75 million shs1.91 million shsThe Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMSAmerican Shared Hospital Services0.00%-4.03%-2.05%+1.42%-43.48%BOLTBolt Biotherapeutics0.00%+16.93%+10.78%-14.17%-20.07%CMECME Group0.00%+1.99%-0.54%-14.75%-10.79%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMSAmerican Shared Hospital Services$1.47+2.4%$1.47$1.25▼$3.11$9.70M0.3128,483 shs12,752 shsBOLTBolt Biotherapeutics$4.47+1.1%$4.47$3.75▼$7.20$8.58M1.1626,337 shs19,926 shsCMECME Group$246.03+0.4%$258.54$218.31▼$329.16$89.16B0.252.75 million shs1.91 million shsThe Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMSAmerican Shared Hospital Services0.00%-4.03%-2.05%+1.42%-43.48%BOLTBolt Biotherapeutics0.00%+16.93%+10.78%-14.17%-20.07%CMECME Group0.00%+1.99%-0.54%-14.75%-10.79%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMSAmerican Shared Hospital Services 0.00N/AN/AN/ABOLTBolt Biotherapeutics 2.40Hold$34.67675.89% UpsideCMECME Group 2.56Moderate Buy$292.1218.73% UpsideCurrent Analyst Ratings BreakdownLatest BOLT, AMS, and CME Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/17/2026BOLTBolt Biotherapeutics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)7/15/2026CMECME Group Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$329.00 ➝ $295.007/13/2026CMECME Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B) ➝ Buy (B-)7/10/2026CMECME Group Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$353.00 ➝ $324.007/9/2026CMECME Group BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$316.00 ➝ $270.007/6/2026CMECME Group UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$310.00 ➝ $260.007/6/2026CMECME Group UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$310.00 ➝ $260.007/2/2026CMECME Group Raymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$320.006/30/2026CMECME Group The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetSell$267.00 ➝ $245.006/25/2026CMECME Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B+) ➝ Buy (B)6/22/2026CMECME Group TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$323.00 ➝ $273.00(Data available from 7/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMSAmerican Shared Hospital Services$28.08M0.35$0.67 per share2.18$4.23 per share0.35BOLTBolt Biotherapeutics$7.70M1.11N/AN/A$13.81 per share0.32CMECME Group$6.52B13.67$12.36 per share19.91$80.03 per share3.07Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMSAmerican Shared Hospital Services-$1.55M$0.60N/AN/AN/A-5.30%-5.51%-2.64%8/12/2026 (Estimated)BOLTBolt Biotherapeutics-$33.38M-$16.33N/AN/AN/A-455.15%-100.89%-48.23%8/13/2026 (Estimated)CMECME Group$4.07B$11.7220.9919.363.0563.19%15.42%2.24%7/22/2026 (Estimated)Latest BOLT, AMS, and CME EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2026Q2 2026BOLTBolt Biotherapeutics-$3.3867N/AN/AN/A$0.50 millionN/A8/12/2026Q2 2026AMSAmerican Shared Hospital Services-$0.02N/AN/AN/A$7.56 millionN/A7/22/2026Q2 2026CMECME Group$2.92N/AN/AN/A$1.68 billionN/A5/14/2026Q1 2026AMSAmerican Shared Hospital Services-$0.01-$0.09-$0.08-$0.09$6.87 million$7.08 million5/12/2026Q1 2026BOLTBolt Biotherapeutics-$2.85-$4.31-$1.46-$4.31$1.50 million$0.03 million4/22/2026Q1 2026CMECME Group$3.11$3.36+$0.25$3.18$1.77 billion$1.88 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAMSAmerican Shared Hospital ServicesN/AN/AN/AN/AN/ABOLTBolt BiotherapeuticsN/AN/AN/AN/AN/ACMECME Group$5.202.11%-3.26%44.37%N/ALatest BOLT, AMS, and CME DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/7/2026CMECME Groupquarterly$1.302.03%6/9/20266/9/20266/25/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMSAmerican Shared Hospital ServicesN/A0.770.77BOLTBolt Biotherapeutics0.983.513.51CMECME Group0.131.021.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMSAmerican Shared Hospital Services23.16%BOLTBolt Biotherapeutics86.70%CMECME Group87.75%Insider OwnershipCompanyInsider OwnershipAMSAmerican Shared Hospital Services25.80%BOLTBolt Biotherapeutics9.40%CMECME Group0.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMSAmerican Shared Hospital Services106.62 million4.92 millionNot OptionableBOLTBolt Biotherapeutics901.92 million1.74 millionNot OptionableCMECME Group3,875362.36 million361.27 millionOptionableBOLT, AMS, and CME HeadlinesRecent News About These CompaniesCME (CME) Q2 Earnings Preview: What You Should Know Beyond the Headline EstimatesJuly 20 at 10:16 AM | zacks.comSEB Asset Management AB Invests $24.38 Million in CME Group Inc. $CMEJuly 20 at 5:35 AM | marketbeat.comCME Group Inc. $CME Shares Sold by Kestra Advisory Services LLCJuly 20 at 4:32 AM | marketbeat.comCantillon Capital Management LLC Has $409.46 Million Stake in CME Group Inc. $CMEJuly 20 at 4:00 AM | marketbeat.comAIA Group Ltd Has $2.37 Million Stake in CME Group Inc. $CMEJuly 20 at 3:19 AM | marketbeat.comCME Group FY2026 EPS Estimate Lowered by Erste Group BankJuly 20 at 1:28 AM | americanbankingnews.comFY2026 EPS Estimates for CME Group Cut by Erste Group BankJuly 20 at 1:27 AM | marketbeat.comTrue North Advisors LLC Purchases New Stake in CME Group Inc. $CMEJuly 19 at 6:23 AM | marketbeat.comSpartan Wealth Advisory Services LLC Makes New $1.67 Million Investment in CME Group Inc. $CMEJuly 19 at 5:51 AM | marketbeat.comProsperity Consulting Group LLC Boosts Stake in CME Group Inc. $CMEJuly 18 at 5:19 AM | marketbeat.comCalifornia Public Employees Retirement System Has $241.11 Million Stock Holdings in CME Group Inc. $CMEJuly 18 at 4:23 AM | marketbeat.comCeera Investments LLC Has $707,000 Holdings in CME Group Inc. $CMEJuly 18 at 4:16 AM | marketbeat.comCME Group Inc. (NASDAQ:CME) Given Consensus Recommendation of "Moderate Buy" by AnalystsJuly 18 at 2:28 AM | americanbankingnews.comCME Group Inc. (NASDAQ:CME) Receives Consensus Recommendation of "Moderate Buy" from AnalystsJuly 18 at 2:28 AM | marketbeat.comWhat's in the Cards for CME Group This Earnings Season?July 17 at 12:40 PM | zacks.comBessemer Group Inc. Increases Stock Holdings in CME Group Inc. $CMEJuly 17 at 4:23 AM | marketbeat.comAware Super Pty Ltd as trustee of Aware Super Makes New $24.05 Million Investment in CME Group Inc. $CMEJuly 17 at 3:12 AM | marketbeat.comBank of New York Mellon Corp Reduces Holdings in CME Group Inc. $CMEJuly 16, 2026 | marketbeat.comBlackrock, CME, Goldman, JPMorgan, NYSE, Nasdaq, Vanguard Among 30+ Firms in DTCC’s Successful Tokenized Trade TestJuly 15, 2026 | news.bitcoin.comCME Group (CME) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseJuly 15, 2026 | zacks.comPiper Sandler Cuts CME Group (NASDAQ:CME) Price Target to $295.00July 15, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSK Hynix’s Nasdaq Listing Could Reset the AI Memory TradeBy Thomas Hughes | July 7, 2026The AI Chip Sell-Off Looks Scary, But the Real Story May Be LiquidityBy Jeffrey Neal Johnson | July 7, 2026Why These South Korea-Focused ETFs Have More Than Doubled in 2026By Nathan Reiff | June 24, 20263 Top Financial Institutions Announce Over $70 Billion in Share RepurchasesBy Leo Miller | June 30, 2026Wedbush Pounds the Table—Buy Sandisk Before August 5 EarningsBy Thomas Hughes | July 14, 2026BOLT, AMS, and CME Company DescriptionsAmerican Shared Hospital Services NYSEAMERICAN:AMS$1.46 +0.04 (+2.45%) As of 03:37 PM Eastern This is a fair market value price provided by Massive. Learn more.American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units; and leases medical equipment. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. The company markets its solutions to cancer treatment centers, hospitals, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.Bolt Biotherapeutics NASDAQ:BOLT$4.47 +0.05 (+1.09%) As of 03:33 PM Eastern This is a fair market value price provided by Massive. Learn more.Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.CME Group NASDAQ:CME$246.03 +0.98 (+0.40%) As of 03:38 PM Eastern This is a fair market value price provided by Massive. Learn more.CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino's Stock Serving Up a Buying Opportunity? AI Data Centers Need Power, and These 2 Industrials Are Cashing In 5 Stocks Quietly Trading Near All-Time Highs While Everyone Watches the AI Drama Meta Platforms Turns AI Power Scarcity Into a $10 Billion Cloud Bet Why Gold Miners Could Be the Market's Biggest Comeback Story A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Amazon’s AI Spending Is About to Face Its Most Important AWS Test Yet Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
